Onderneming Cocrystal Pharma Inc OTC Bulletin Board
Aandelen
US19188J1025
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sam Lee
CEO | Chief Executive Officer | 64 | 02-01-14 |
James Martin
CEO | Chief Executive Officer | 57 | 23-02-17 |
Roger Kornberg
CHM | Chairman | 76 | 02-01-14 |
Luz Pascual
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Phillip Frost
BRD | Director/Board Member | 87 | 02-01-14 |
Director/Board Member | 68 | 27-05-21 | |
Steven Rubin
BRD | Director/Board Member | 63 | 02-01-14 |
Fred Hassan
BRD | Director/Board Member | 78 | 20-04-23 |
Anthony Japour
BRD | Director/Board Member | 64 | 04-04-19 |
Roger Kornberg
CHM | Chairman | 76 | 02-01-14 |
Sam Lee
CEO | Chief Executive Officer | 64 | 02-01-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 173 790 | 7 118 419 ( 69,97 %) | 0 | 69,97 % |
Bedrijfsgegevens
Cocrystal Pharma, Inc.
19805 North Creek Parkway
98011, Bothell
+877 262 7123
http://www.cocrystalpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,72% | 125 mld. | |
+14,19% | 108 mld. | |
-4,93% | 24,57 mld. | |
+3,23% | 22,82 mld. | |
-10,44% | 18,19 mld. | |
-41,74% | 16,54 mld. | |
-13,31% | 16,5 mld. | |
+2,44% | 13,39 mld. | |
+27,89% | 11,1 mld. |